REPRODIVAC - Next-generation vaccines and diagnostics to prevent livestock reproductive diseases of worldwide impact

Institutions

REPRODIVAC project : 16 partners in 7 European countries.

1

Italian National Agency for New Technologies, Energy and Sustainable Economic Development

Italian National Agency for New Technologies, Energy and Sustainable Economic Development

Plant-based expression platform for the production of recombinant proteins. Development of vaccine delivery strategies based on rational antigen design.

ENEA

Italy

2

Wageningen University & Research

Wageningen University & Research

Microbiology laboratory (BSL3) with specific expertise regarding diagnosis and host-pathogen interaction studies of bacterial zoonotic pathogens and infections (Q fever, Tuberculosis, Brucellosis).

WUR

Netherlands

4

University of Lleida

University of Lleida

Diagnosis of swine diseases. Extensive experience in performing epidemiological studies for bacterial and viral diseases in livestock.

UdL

Spain

4a

Centre D’estudis Porcins

Centre D’estudis Porcins

Affiliated entity of the UdL with facilities to carry out animal experiments with BSL2 requirements.

CEP

Spain

5

Ceva Animal Health

Ceva Animal Health

Facilities for large scale production of vaccine antigens at BSL3. Expertise in vaccine manufacture and commercialisation.

CEVA

France

6

Friedrich Loeffler Institut

Friedrich Loeffler Institut

Microbiology laboratories (BSL2 to BSL3) with specific expertise regarding diagnosis and host-pathogen interaction studies of viral and bacterial infections including Pseudorabies virus, Chlamydia abortus and Coxiella burnetii.

FLI

Germany

7

Centro De Investigacion Y Tecnologia Agroalimentaria De Aragón

Centro De Investigacion Y Tecnologia Agroalimentaria De Aragón

Expertise in animal models for evaluating brucellosis vaccines and development and assessment of diagnostic tests. Expertise on brucellosis control and eradication strategies.

CITA

Spain

8

University of Navarra

University of Navarra

Expertise in Brucella genetics, virulence factors and immune response mechanisms.

UON

Spain

9

University of Murcia

University of Murcia

Microbiology, pathology, and immunology of Chlamydia abortus infections, including in the mouse model.

UMU

Spain

10

École Polytechnique Fédérale de Lausanne

École Polytechnique Fédérale de Lausanne

Protein engineering, computational design, immunoengineering, and synthetic biology.

EPFL

Switzerland

11

Associacio Porcsa-Grup de Sanejament Porcì

Associacio Porcsa-Grup de Sanejament Porcì

Diagnostic laboratory specialised in swine diseases that cover 60% of the Spanish pig production.

GSP

Spain

12

CZ Veterinaria S.A. - CZ Vaccines

CZ Veterinaria S.A. - CZ Vaccines

Expertise in vaccine manufacture and commercialisation.

CZV

Spain

13

Global DX Ltd

Global DX Ltd

Development and commercialisation of veterinary Point-of-Care tests.

GDX

United Kingdom

14

Pirbright Institute

Pirbright Institute

Porcine and ruminant immunology. Isolation and recombinant expression of monoclonal antibodies from livestock. Porcine Reproductive Respiratory Syndrome immunobiology and vaccinology.

TPI

United Kingdom

15

Moredun Research Institute

Moredun Research Institute

Pathogen biology, host-pathogen interactions, and ruminant immunology. Control and diagnosis of infectious diseases of livestock resulting from bacterial zoonotic pathogens (Chalmydia abortus and Q fever).

MRI

United Kingdom

16

École normale supérieure de Lyon

École normale supérieure de Lyon

Virus particles structure determination by cryo electron toÉcole normale supérieure de Lyon École normale supérieure de Lyonmography and subtomogram averaging, structure analysis.

ENSL

France

REPRODIVAC has received funding from the European Union’s Horizon Europe research and innovation programme under Grant Agreement No. 101060813. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or other granting authorities. Neither the European Union nor the other granting authorities can be held responsible for them.

REPRODIVAC has received funding from the European Union’s Horizon Europe research and innovation programme under Grant Agreement No. 101060813. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or other granting authorities. Neither the European Union nor the other granting authorities can be held responsible for them.

Feedback